Statera BioPharma (FRA:7CB) Dividends per Share: €0.00 (TTM As of Sep. 2022)


FRA:7CB Statera BioPharma Inc FRA:7CB
20 GF Score
Price €2.61
View Full Analysis

What is Statera BioPharma Dividends per Share?

Statera BioPharma FRA:7CB 20 Dividends per Share is €0.00 as of Sep. 2022. GuruFocus rates FRA:7CB with a GF Score™ of 20/100.

Statera BioPharma's dividends per share for the three months ended in Sep. 2022 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2022 was €0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2022 was 0.00. As of today, Statera BioPharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Statera BioPharma  (FRA:7CB) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Statera BioPharma's Dividend Payout Ratio for the quarter that ended in Sep. 2022 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2022 )/ EPS without NRI (Q: Sep. 2022 )
=0/ -0.066
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Dividends per Share Related Terms

Statera BioPharma Dividends per Share Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Dividends per Share Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Dividends per Share
0.00 0.00 0.00

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:7CB vs NRBO, PALI, BLCM: Dividends per Share Comparison

For the Biotechnology subindustry, Statera BioPharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's Dividend Yield % falls into.


FRA:7CB
20GF Score
Statera BioPharma Inc FRA:7CB
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Statera BioPharma Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of €0.00 mean?
Statera BioPharma (FRA:7CB) has a Dividends per Share of €0.00 as of Sep. 2022. Dividends per share represents the per-share amount paid as dividends. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's Dividends per Share too high?
Statera BioPharma's current Dividends per Share is €0.00. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Dividends per Share compare to NRBO and PALI?
Statera BioPharma's Dividends per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (FRA:7CB) has a current Dividends per Share of €0.00. The current Dividends per Share is €0.00. Statera BioPharma's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Statera BioPharma (FRA:7CB), the current Dividends per Share is €0.00 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
20GF Score

Get the complete analysis for FRA:7CB

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.61
Price